QbD-Enabled Development of Quercetin Dihydrate-Loaded Nanostructured Lipid Carriers: In Vitro Characterization, Safety and Efficacy Assessment in Androgenetic Alopecia Mice Model

    February 2025 in “ BioNanoScience ”
    Meenaz M. Sayyed, Tulshidas S. Patil, Tanaya D. Khairnar … Yogeeta O. Agrawal
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 25

    1. Recent Trends in Nanocarrier Formulations of Actives Beyond Minoxidil and 5-Alpha Reductase Inhibitors in Androgenetic Alopecia Management: A Systematic Review Journal of Drug Delivery Science and Technology · 2024
    2. Status of Research on the Development and Regeneration of Hair Follicles International Journal of Medical Sciences · 2023
    3. Androgenetic Alopecia: An Update JAAD International · 2023
    4. Activity and Safety of Cinchonine Nanostructured Lipid Carriers as a Hair Growth Stimulant in Mice Model of Androgenetic Alopecia Sains Malaysiana · 2023
    5. Androgenetic Alopecia: Therapy Update Drugs · 2023
    6. The Efficacy and Safety of Oral and Topical Spironolactone in Androgenetic Alopecia Treatment: A Systematic Review Clinical, Cosmetic and Investigational Dermatology · 2023
    7. Formulation Development and Investigations on Therapeutic Potential of Nanogel from Beta Vulgaris L. Extract in Testosterone-Induced Alopecia BioMed Research International · 2023
    8. A Combination Therapy for Androgenic Alopecia Based on Quercetin and Zinc/Copper Dual-Doped Mesoporous Silica Nanocomposite Microneedle Patch Bioactive Materials · 2022
    9. Treatment Options for Androgenetic Alopecia: Efficacy, Side Effects, Compliance, Financial Considerations, and Ethics Journal of Cosmetic Dermatology · 2021
    10. A Systematic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia Natural Products and Bioprospecting · 2020
    11. Phospholipid-Polymer Hybrid Nanoparticle-Mediated Transfollicular Delivery of Quercetin: Prospective Implementation for the Treatment of Androgenic Alopecia Drug Development and Industrial Pharmacy · 2019
    12. Cyproterone Acetate-Loaded Nanostructured Lipid Carriers: Effect of Particle Size on Skin Penetration and Follicular Targeting Pharmaceutical development and technology · 2019
    13. Clinical Cosmeceutical Repurposing of Melatonin in Androgenic Alopecia Using Nanostructured Lipid Carriers Prepared with Antioxidant Oils Expert Opinion on Drug Delivery · 2018
    14. Male Pattern Baldness and Incidence of Prostate Cancer Medicine · 2018
    15. Androgenetic Alopecia: A Review Endocrine · 2017
    16. Dutasteride in Androgenetic Alopecia: An Update Current Clinical Pharmacology · 2017
    17. Frequency, Severity, and Related Factors of Androgenetic Alopecia in Dermatology Outpatient Clinic: Hospital-Based Cross-Sectional Study in Turkey Anais Brasileiros De Dermatologia · 2017
    18. Histological Evaluation of Follicular Delivery of Arginine via Nanostructured Lipid Carriers: A Novel Potential Approach for the Treatment of Alopecia Artificial Cells Nanomedicine and Biotechnology · 2016
    19. Follicular Delivery of Spironolactone via Nanostructured Lipid Carriers for Management of Alopecia International Journal of Nanomedicine · 2014
    20. A Comparative In Vivo and In Vitro Evaluation of Hair Growth Potential of Extracts and an Isolate from Petroleum Ether Extract of Cuscuta Reflexa Roxb Beni-Suef University Journal of Basic and Applied Sciences · 2014
    21. Androgenetic Alopecia: An Evidence-Based Treatment Update American Journal of Clinical Dermatology · 2014
    22. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carrier Gel for Effective Treatment of Alopecia Journal of The Saudi Pharmaceutical Society · 2013
    23. Androgenetic Alopecia: An Update Indian Journal of Dermatology, Venereology and Leprology · 2013
    24. Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study Journal of The American Academy of Dermatology · 2010
    25. Androgens and Alopecia Molecular and Cellular Endocrinology · 2002